BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 29608129)

  • 1. HIV-Infected Women Gain More Weight than HIV-Infected Men Following the Initiation of Antiretroviral Therapy.
    Bares SH; Smeaton LM; Xu A; Godfrey C; McComsey GA
    J Womens Health (Larchmt); 2018 Sep; 27(9):1162-1169. PubMed ID: 29608129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada.
    Koethe JR; Jenkins CA; Lau B; Shepherd BE; Justice AC; Tate JP; Buchacz K; Napravnik S; Mayor AM; Horberg MA; Blashill AJ; Willig A; Wester CW; Silverberg MJ; Gill J; Thorne JE; Klein M; Eron JJ; Kitahata MM; Sterling TR; Moore RD;
    AIDS Res Hum Retroviruses; 2016 Jan; 32(1):50-8. PubMed ID: 26352511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body mass index and early CD4 T-cell recovery among adults initiating antiretroviral therapy in North America, 1998-2010.
    Koethe JR; Jenkins CA; Lau B; Shepherd BE; Silverberg MJ; Brown TT; Blashill AJ; Anema A; Willig A; Stinnette S; Napravnik S; Gill J; Crane HM; Sterling TR;
    HIV Med; 2015 Oct; 16(9):572-7. PubMed ID: 25960080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body mass index, immune status, and virological control in HIV-infected men who have sex with men.
    Blashill AJ; Mayer KH; Crane HM; Grasso C; Safren SA
    J Int Assoc Provid AIDS Care; 2013; 12(5):319-24. PubMed ID: 23719237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy.
    Koethe JR; Jenkins CA; Shepherd BE; Stinnette SE; Sterling TR
    Clin Infect Dis; 2011 Nov; 53(9):952-60. PubMed ID: 21946189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does gender or mode of HIV acquisition affect virological response to modern antiretroviral therapy (ART)?
    Saunders P; Goodman AL; Smith CJ; Marshall N; O'Connor JL; Lampe FC; Johnson MA
    HIV Med; 2016 Jan; 17(1):18-27. PubMed ID: 26140659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive effects of body mass index on immune reconstitution among HIV-infected HAART users in China.
    Li X; Ding H; Geng W; Liu J; Jiang Y; Xu J; Zhang Z; Shang H
    BMC Infect Dis; 2019 May; 19(1):373. PubMed ID: 31046702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.
    Soria A; Porten K; Fampou-Toundji JC; Galli L; Mougnutou R; Buard V; Kfutwah A; Vessière A; Rousset D; Teck R; Calmy A; Ciaffi L; Lazzarin A; Gianotti N
    Antivir Ther; 2009; 14(3):339-47. PubMed ID: 19474468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US.
    Antiretroviral Therapy Cohort Collaboration (ART-CC)
    Antivir Ther; 2015; 20(1):21-8. PubMed ID: 24675571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial.
    Guehi C; Badjé A; Gabillard D; Ouattara E; Koulé SO; Moh R; Ekouevi D; Ahibo H; N'Takpé JB; Menan GK; Deschamps N; Lecarrou J; Eholié S; Anglaret X; Danel C
    AIDS Res Ther; 2016; 13():12. PubMed ID: 26925155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced immunovirological response in women compared to men after antiretroviral therapy initiation during acute and early HIV-1 infection: results from a longitudinal study in the French ANRS Primo cohort.
    Novelli S; Delobel P; Bouchaud O; Avettand-Fenoel V; Fialaire P; Cabié A; Souala F; Raffi F; Catalan P; Weiss L; Meyer L; Goujard C
    J Int AIDS Soc; 2020 Apr; 23(4):e25485. PubMed ID: 32333726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study.
    Achhra AC; Mocroft A; Reiss P; Sabin C; Ryom L; de Wit S; Smith CJ; d'Arminio Monforte A; Phillips A; Weber R; Lundgren J; Law MG;
    HIV Med; 2016 Apr; 17(4):255-68. PubMed ID: 26216031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in nutritional, functional and immunological status of HIV-infected adults with antiretroviral therapy.
    Tafese Z; Berhan Y; Abebe H
    Ethiop Med J; 2012 Jan; 50(1):75-87. PubMed ID: 22519164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in mortality and CD4 count response among virally suppressed HIV-positive patients.
    Maskew M; Brennan AT; Westreich D; McNamara L; MacPhail AP; Fox MP
    J Womens Health (Larchmt); 2013 Feb; 22(2):113-20. PubMed ID: 23350862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of CD4+ T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression.
    Byakwaga H; Murray JM; Petoumenos K; Kelleher AD; Law MG; Boyd MA; Emery S; Mallon PW; Cooper DA
    AIDS Res Hum Retroviruses; 2009 Jun; 25(6):756-76. PubMed ID: 19500017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance change and antiretroviral therapy exposure in HIV-infected and uninfected Rwandan women: a longitudinal analysis.
    Mutimura E; Hoover DR; Shi Q; Dusingize JC; Sinayobye JD; Cohen M; Anastos K
    PLoS One; 2015; 10(4):e0123936. PubMed ID: 25880634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors.
    Bakal DR; Coelho LE; Luz PM; Clark JL; De Boni RB; Cardoso SW; Veloso VG; Lake JE; Grinsztejn B
    J Antimicrob Chemother; 2018 Aug; 73(8):2177-2185. PubMed ID: 29722811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.